Similar articles for PMID: 23460112

Year	Number of Results
1996	1
1998	2
1999	1
2000	1
2001	4
2002	6
2003	2
2004	8
2005	8
2006	7
2007	7
2008	9
2009	1
2011	7
2012	6
2013	9
2014	4
2015	3
2016	3
2017	1
2019	1
2020	2
2021	1
2024	0

1

Effect of atorvastatin on hematologic parameters in patients with hypercholesterolemia.

Akin F, Ayça B, Köse N, Sahin I, Akin MN, Canbek TD, Güngör O. Akin F, et al. Angiology. 2013 Nov;64(8):621-5. doi: 10.1177/0003319713479154. Epub 2013 Mar 4. Angiology. 2013. PMID: 23460112

2

Effect of atorvastatin on hematologic parameters in patients with hypercholesterolemia.

Akin F, Ayça B, Köse N. Akin F, et al. Angiology. 2014 Aug;65(7):651. doi: 10.1177/0003319713520419. Epub 2014 Feb 17. Angiology. 2014. PMID: 24535640 No abstract available.

3

Atorvastatin treatment decreases inflammatory and proteolytic activity in patients with hypercholesterolemia.

Ercan E, Tengiz I, Altuglu I, Sekuri C, Aliyev E, Ercan HE, Akin M. Ercan E, et al. Kardiol Pol. 2004 May;60(5):454-8. Kardiol Pol. 2004. PMID: 15247960 Clinical Trial.

4

Mean platelet volume measurement in patients with hypercholesterolemia: a methodological issue.

Varol E, Ozaydin M. Varol E, et al. Angiology. 2013 Nov;64(8):626. doi: 10.1177/0003319713490824. Epub 2013 May 24. Angiology. 2013. PMID: 23709475 No abstract available.

5

Impact of atorvastatin on serum vaspin levels in hypercholesterolemic patients with moderate cardiovascular risk.

Kadoglou NP, Vrabas IS, Kapelouzou A, Lampropoulos S, Sailer N, Kostakis A, Liapis CD. Kadoglou NP, et al. Regul Pept. 2011 Oct 10;170(1-3):57-61. doi: 10.1016/j.regpep.2011.05.008. Epub 2011 Jun 2. Regul Pept. 2011. PMID: 21640762 Clinical Trial.

6

The effects of atorvastatin treatment on the mean platelet volume and red cell distribution width in patients with dyslipoproteinemia and comparison with plasma atherogenicity indicators--A pilot study.

Kucera M, Balaz D, Kruzliak P, Ciccocioppo R, Oravec S, Rodrigo L, Zulli A, Hirnerova E, Sabaka P, Komornikova A, Sabo J, Slezak P, Gaspar L. Kucera M, et al. Clin Biochem. 2015 Jun;48(9):557-61. doi: 10.1016/j.clinbiochem.2015.02.010. Epub 2015 Feb 26. Clin Biochem. 2015. PMID: 25727667

7

Immediate antioxidant and antiplatelet effect of atorvastatin via inhibition of Nox2.

Pignatelli P, Carnevale R, Pastori D, Cangemi R, Napoleone L, Bartimoccia S, Nocella C, Basili S, Violi F. Pignatelli P, et al. Circulation. 2012 Jul 3;126(1):92-103. doi: 10.1161/CIRCULATIONAHA.112.095554. Epub 2012 May 21. Circulation. 2012. PMID: 22615342 Clinical Trial.

8

Long-term (18-month) efficacy of atorvastatin therapy in type 2 diabetics at cardiovascular risk.

Velussi M. Velussi M. Nutr Metab Cardiovasc Dis. 2002 Feb;12(1):29-35. Nutr Metab Cardiovasc Dis. 2002. PMID: 12125227

9

Lipitor (atorvastatin calcium) tablets.

Claussen DW. Claussen DW. Gastroenterol Nurs. 1998 Sep-Oct;21(5):219-20. doi: 10.1097/00001610-199809000-00008. Gastroenterol Nurs. 1998. PMID: 9830966 Review. No abstract available.

10

Ezetimibe/simvastatin vs atorvastatin in patients with type 2 diabetes mellitus and hypercholesterolemia: the VYTAL study.

Goldberg RB, Guyton JR, Mazzone T, Weinstock RS, Polis A, Edwards P, Tomassini JE, Tershakovec AM. Goldberg RB, et al. Mayo Clin Proc. 2006 Dec;81(12):1579-88. doi: 10.4065/81.12.1579. Mayo Clin Proc. 2006. PMID: 17165637 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

84 results

Results by year